ライフサイエンスコーパス: Hirschsprung's disease

1 linked to incomplete ENS formation, such as Hirschsprung's disease.

2 tic approaches to neurocristopathies such as Hirschsprung's disease.

3 understanding newer therapeutic options for Hirschsprung's disease.

4 olons, and premature death, resembling human Hirschsprung's disease.

5 cristopathies, Waardenburg-Shah syndrome and Hirschsprung's disease.

6 ll migration have been shown to give rise to Hirschsprung's disease.

7 tive colitis, familial colonic polyposis, or Hirschsprung's disease.

8 lial medullary thyroid carcinoma (FMTC), and Hirschsprung's disease.

9 tunities in the treatment of severe forms of Hirschsprung's disease.

10 to human bowel motility disorders, including Hirschsprung's disease.

11 specific expression of genes associated with Hirschsprung's disease.

12 coding elements defined a widespread risk of Hirschsprung's disease (48.4% of patients and 17.1% of c

13 entiation, together with features typical of Hirschsprung's disease (aganglionic colon).

14 n colon samples from pediatric patients with Hirschsprung's disease and patients with chronic pseudo

15 nd mice, mutations in the Ret gene result in Hirschsprung's disease and renal defects.

16 Among the patients in our study, Hirschsprung's disease arose from common noncoding varia

17 ntrast, a RET mutant found in a patient with Hirschsprung's disease, as well as a RET/PTC1 mutant wit

18 A one-stage pull-through for Hirschsprung's disease avoids the additional anesthesia,

19 es to the treatment of congenital megacolon (Hirschsprung's disease) based on the colonisation of the

20 ng leads to aganglionosis of the distal gut (Hirschsprung's disease), but it is unclear whether it is

21 stigate the cellular and molecular basis for Hirschsprung's disease caused by a mutation in the gene

22 Recent trends in surgery for Hirschsprung's disease have been toward earlier repair a

23 Hirschsprung's disease (HD) is a congenital disorder cha

24 Hirschsprung's disease (HD) is a congenital structural a

25 addition, some patients with MEN 2A develop Hirschsprung's disease (HD), and all patients with MEN 2

26 entification of gold-standard treatments for Hirschsprung's Disease(HD) and gastroschisis.

27 Hirschsprung's disease (HSCR) causes functional intestin

28 Hirschsprung's disease (HSCR) is a severe congenital ano

29 rom variable lengths of the colon results in Hirschsprung's disease (HSCR) or colonic aganglionosis.

30 l and acquired enteric neuropathies, such as Hirschsprung's disease (HSCR), achalasia, intestinal neu

31 d to neurogastrointestinal disorders such as Hirschsprung's disease (HSCR), in which the ENS plays a

32 nd results in a condition in humans known as Hirschsprung's disease (HSCR).

33 vous system (ENS) development is relevant to Hirschsprung's disease (HSCR; congenital aganglionosis o

34 e lack of ganglia in the terminal hindgut of Hirschsprung's disease in humans or aganglionic megacolo

35 nesis of the inhibitory neurotransmission in Hirschsprung's disease in the distal colon and IAS.

36 Hirschsprung's disease is defined by the absence of the

37 The pathogenesis of Hirschsprung's disease is not well understood.

38 s with defective migration of NCC that model Hirschsprung's disease, leading us to hypothesize that t

39 , anorectal malformations in 24 (47.1%), and Hirschsprung's disease, necrotising enterocolitis, and v

40 when they were significantly associated with Hirschsprung's disease or another neurodevelopmental dis

41 Hirschsprung's disease, or congenital aganglionosis, is

42 additional candidate genes that could modify Hirschsprung's disease penetrance.

43 colons and 1 ileal specimen resected during Hirschsprung's disease pull-through surgery were cleared

44 r individual patients, the estimated risk of Hirschsprung's disease ranged from 5.33 cases per 100,00

45 ome-sequenced samples from 190 patients with Hirschsprung's disease to quantify the genetic burden in

46 hogenesis of inhibitory neurotransmission in Hirschsprung's disease was investigated.

47 usly shown to have a role in the etiology of Hirschsprung's disease, was misregulated within the gut

48 We report a 25-year-old woman with CCHS (no Hirschsprung's disease) who gave birth to a daughter who

49 s of a complex developmental anomaly such as Hirschsprung's disease will rely on unravelling its path

50 infectious diarrhea with zinc; achalasia and Hirschsprung's disease with botulinum toxin; weight loss

51 ced enteric nervous system characteristic of Hirschsprung's disease with reduced pigment cell number,